Search

Displaying results 7611 - 7620 of 10000 in total
  1. Drug

    Managlinat dialanetil

    go.drugbank.com/drugs/DB05518
    Investigational

    CS-917 is a novel inhibitor of fructose 1,6-bisphphosphatase (FBPase) which is one of the rate-limiting enzymes of gluconeogenesis.

  2. Drug

    Navarixin

    go.drugbank.com/drugs/DB11711
    Investigational

    Navarixin has been investigated for the treatment of Asthma.

  3. Drug

    Sarcosine

    go.drugbank.com/drugs/DB12519
    Investigational

    Sarcosine has been investigated for the treatment of Schizophrenia.

  4. Drug

    Pyronaridine

    go.drugbank.com/drugs/DB12975
    Investigational

    Pyronaridine has been investigated for the treatment of Malaria.

  5. Drug

    99mTc-14 F7 Mab

    go.drugbank.com/drugs/DB05867
    Experimental

    Growth inhibition and prolonged survival of the myeloma tumor were obtained as evidences of anti tumor effect after treatment with 99mTc 14F7 Mab.

  6. Drug

    Galamustine

    go.drugbank.com/drugs/DB21062
    Experimental

    The usage of the INN stem '-mustine' in the name indicates that Galamustine is a antineoplastic, alkylating agent, (β-chloroethyl) amine derivative.

  7. Drug

    Viquidacin

    go.drugbank.com/drugs/DB19549
    Experimental

    The usage of the INN stem '-dacin' in the name indicates that Viquidacin is a antibiotic, DNA gyrase and topoisomerase IV inhibitor. Viquidacin has a monoisotopic molecular weight of 504.16 Da.

  8. Drug

    Barucainide

    go.drugbank.com/drugs/DB19585
    Experimental

    The usage of the INN stem '-cain-' in the name indicates that Barucainide is a class I antiarrhythmic, procainamide and lidocaine derivative.

  9. Drug

    Suricainide

    go.drugbank.com/drugs/DB19705
    Experimental

    The usage of the INN stem '-cain-' in the name indicates that Suricainide is a class I antiarrhythmic, procainamide and lidocaine derivative.

  10. Drug

    Abitesartan

    go.drugbank.com/drugs/DB19863
    Experimental

    The usage of the INN stem '-sartan' in the name indicates that Abitesartan is a angiotensin II receptor antagonist, antihypertensive (non-peptidic).